Santa Fe Partners’s Charles River Laboratories CRL Stock Holding History

Santa Fe Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,955	Closed	-$1.28M	–	73
2015 Q4	$1.28M	Buy	15,955 +7,160	+81%	+$516K	0.21%	186
2015 Q3	$559K	Buy	8,795 +4,674	+113%	+$336K	0.07%	339
2015 Q2	$289K	Sell	4,121 -14,297	-78%	-$1.06M	0.04%	435
2015 Q1	$1.46M	Buy	18,418 +14,182	+335%	+$1.05M	0.18%	243
2014 Q4	$270K	Sell	4,236 -14,557	-77%	-$913K	0.03%	440
2014 Q3	$1.12M	Buy	18,793 +562	+3%	+$32.2K	0.17%	234
2014 Q2	$975K	Sell	18,231 -18,813	-51%	-$1.03M	0.15%	273
2014 Q1	$2.24M	Buy	37,044 +26,558	+253%	+$1.55M	0.32%	120
2013 Q4	$556K	Sell	10,486 -3,533	-25%	-$177K	0.09%	329
2013 Q3	$650K	Buy	+14,019	New	+$643K	0.12%	277

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Santa Fe Partners's CRL Position: Q1 2016 in Review

Santa Fe Partners sold out of Charles River Laboratories (CRL) in Q1 2016, closing a stake of 15,955 shares — an estimated $1.28M sold.

Santa Fe Partners first reported a position in CRL in Q3 2013 and held it in 10 quarters. The position peaked at $2.24M in Q1 2014. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

Santa Fe Partners reported no remaining Charles River Laboratories position as of Q1 2016 after selling out during the quarter.
Santa Fe Partners sold 15,955 Charles River Laboratories shares in Q1 2016, an estimated $1.28M.
Santa Fe Partners first reported a position in Charles River Laboratories in Q3 2013 and held it in 10 quarters.
Santa Fe Partners's Charles River Laboratories position peaked at $2.24M in Q1 2014.
264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.